Middle Eastern Countries Look to Decrease Pharmaceutical Imports

Eighty percent of drugs consumed in the Middle East are currently imported, but governments across the region are trying to change that by boosting domestic manufacturing and joint ventures and licensing deals, according to Frost & Sullivan’s analysis of the Gulf Cooperation Council pharmaceutical market. The reliance on drug and raw material imports, especially in Saudi Arabia and the United Arab Emirates, coupled with low R&D capability, are the main market constraints, Manisha Rawat said.
International Pharmaceutical Regulatory Monitor